Johnson & Johnson makes prescription drugs and medical devices — from cancer treatments to surgical tools.
Johnson & Johnson (JNJ) is expected to report earnings on Wednesday, January 20, 2027, after the close. Estimated release time 07:41 ET. Consensus EPS estimate is $2.93.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-10-13 | Sep 2026 qtr | $2.52 | $2.59 | +2.8% | $25.40B |
| 2026-07-15 | Jun 2026 qtr | $2.84 | $2.90 | +2.1% | $25.31B |
| 2026-04-14 | Mar 2026 qtr | $2.68 | $2.70 | +0.7% | $24.06B |
| 2026-01-21 | Dec 2025 qtr | $2.46 | $2.46 | +0.0% | $24.56B |
| 2025-10-14 | Sep 2025 qtr | $2.76 | $2.80 | +1.4% | $23.99B |
| 2025-07-16 | Jun 2025 qtr | $2.68 | $2.77 | +3.4% | $23.74B |
| 2025-04-15 | Mar 2025 qtr | $2.58 | $2.77 | +7.4% | $21.89B |
| 2025-01-22 | Dec 2024 qtr | $1.99 | $2.04 | +2.5% | $22.52B |
JNJ has beaten consensus EPS in 8 of its last 8 scored quarters.
JNJ pays a quarterly dividend, currently yielding 2.14%.
| Ex-dividend date | Amount | Paid |
|---|---|---|
| 2026-11-24 | $1.34 | 2026-12-08 |
| 2026-08-25 | $1.34 | 2026-09-08 |
| 2026-05-26 | $1.34 | 2026-06-09 |
| 2026-02-24 | $1.3 | 2026-03-10 |
| 2025-11-25 | $1.3 | 2025-12-09 |
| 2025-08-26 | $1.3 | 2025-09-09 |